The transmission of an infectious agent from one host to another is critical to the success of any pathogen. In the case of HIV, a successful transmission is dependent on the ability of the virus to transverse a mucosal membrane (rectal, penile, vaginal or oral) of a new host and establish a productive infection. This proposal builds on findings we obtained while undertaking a previous grant funded by the NIH (NIDCR) (1999 to 2003) to assess the earliest events following oral transmission of SIV in the macaque model. Oral transmission of HIV represents a major route of transmission from mother to infant, through ingesting the virus during breast-feeding;as well as in adults during oral genital transmission (virus in semen). One major finding from our previous studies was the identification of the oral mucosa, esophagus and tonsils as sites of SIV entry following a nontraumatic oral application of the virus and the assessment of the innate and adaptive immune responses that correlate with the rates of disease progression. Here we expand upon our previous findings by assessing the impact of immune activation on the transmission of SIV administered into the oral cavity. We hypothesize that higher levels of immune activation will increase the potential for SIV to elicit a productive infection when administered to the oral cavity of macaques. These studies will utilize a low dose regimen of viral inoculations to mimic the viral levels that are present in breast milk and semen. The goal of specific aim 1 is to determine the appropriate viral inoculum to undertake aim two, and to investigate the correlates of viral transmission in the absence of any immune modifications.
Aim 2 will assess transmission of SIV while the mucosa is experiencing a state of immune activation, gingivitis. Gingivitis is a common inflammation of the oral mucosa in humans and therefore may be impacting oral transmission in humans exposed to HIV containing semen (through receptive oral intercourse). These studies assessing the impact of the immune response on oral transmission will likely be applicable to other sites of mucosal transmission, and will be important for determining the immune mechanisms that impact the success of SIV/HIV mucosal transmission. Our long term goal is to utilize these findings to aid in the design of SIV/HIV vaccines that are able to elicit sterilizing immunity by preventing the infection of the first target cell when mucosal sites are exposed to HIV/SIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE017541-05
Application #
7809633
Study Section
Special Emphasis Panel (ZRG1-AARR-C (02))
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
2007-05-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2012-04-30
Support Year
5
Fiscal Year
2010
Total Cost
$752,438
Indirect Cost
Name
Seattle Biomedical Research Institute
Department
Type
DUNS #
070967955
City
Seattle
State
WA
Country
United States
Zip Code
98109
Kilgore, Katie M; Murphy, Megan K; Burton, Samantha L et al. (2015) Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope. J Virol 89:8130-51
Giavedoni, Luis D; Chen, Hui-Ling; Hodara, Vida L et al. (2013) Impact of mucosal inflammation on oral simian immunodeficiency virus transmission. J Virol 87:1750-8
Wood, Lianna F; Chahroudi, Ann; Chen, Hui-Ling et al. (2013) The oral mucosa immune environment and oral transmission of HIV/SIV. Immunol Rev 254:34-53
Mir, Kiran D; Bosinger, Steven E; Gasper, Melanie et al. (2012) Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys. J Virol 86:7605-15
Durudas, Andre; Chen, Hui-Ling; Gasper, Melanie A et al. (2011) Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques. Curr HIV Res 9:276-88
Milush, Jeffrey M; Mir, Kiran D; Sundaravaradan, Vasudha et al. (2011) Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. J Clin Invest 121:1102-10
Leone, Amanda; Rohankhedkar, Mukta; Okoye, Afam et al. (2010) Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. J Immunol 185:1650-9
Durudas, Andre; Milush, Jeffrey M; Chen, Hui-Ling et al. (2009) Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys. J Virol 83:12229-40
Kosub, David A; Durudas, Andre; Lehrman, Ginger et al. (2008) Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques. Curr HIV Res 6:520-30
Kosub, David A; Lehrman, Ginger; Milush, Jeffrey M et al. (2008) Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J Virol 82:1155-65

Showing the most recent 10 out of 11 publications